MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611078445 A) filed by Anurag Varshney; and Shruti Varshney on June 25, 2026, for Next-Generation Drug For Obesity And Cardiometabolic Disorders Based On Semaglutide, Tirzepatide, Liraglutide, Berobenatide, Danuglipron, Met-233i And Next-Generation Multi-Agonist Peptide And Multi- Hormonal Peptide Combinations.
Inventors include Anurag Varshney; and Shruti Varshney.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to novel pharmaceutical compositions, multi-agonist peptide therapeutics, and advanced drug delivery systems for the prevention, treatment, management, and ...